The U.S. Food and Drug Administration has put forward a proposed rule that would oblige foreign producers of tobacco products to register their manufacturing facilities and supply detailed listings of products sold in the United States. The agency said the change is intended to help address illegal imports, including e-cigarettes that have gained popularity with young people.
Under the proposal, the registration and product-listing requirement would apply to both foreign and domestic entities that manufacture, prepare or process tobacco products for the U.S. market. At present, U.S. manufacturers such as Philip Morris International are already required by federal law to register their facilities and list products with the FDA; foreign manufacturers are not subject to those same obligations under current rules.
The FDA said the proposed rule would close that disparity and could have implications for large international tobacco companies as well as smaller overseas firms. Specifically, the agency named major global tobacco makers that could be affected - British American Tobacco, Japan Tobacco and Imperial Brands - and noted that smaller foreign e-cigarette manufacturers whose products are shipped into the United States may also fall within the new requirements.
According to the agency, the change would yield improved information about tobacco products manufactured abroad for the U.S. market and would enable more effective inspections of foreign facilities. Bret Koplow, acting director of the FDA's Center for Tobacco Products, is quoted by the agency as saying: "All companies selling tobacco products in the United States should play by the same rules."
If the rule is adopted, manufacturers would be required to provide identifying information for each tobacco product they supply to the U.S. market. The data specified by the agency would include nicotine concentration, nicotine source, flavors, package types and product dimensions.
For electronic cigarettes, the FDA's proposed data fields would extend to product-specific technical details such as e-liquid volume, battery capacity and wattage. The agency also outlined how the information should be transmitted and kept current - manufacturers would submit data electronically through the FDA's online system, update facility registrations annually, and refresh product listings twice a year.
The proposal is presented as a step to harmonize regulatory requirements for all companies selling tobacco products in the United States and to strengthen the agency's ability to monitor products manufactured overseas. The rule remains a proposal and would require further action before becoming binding.
Summary
The FDA has proposed a rule to require foreign tobacco product manufacturers to register facilities and list products sold in the United States, aiming to close a regulatory gap and improve oversight of imports - including e-cigarettes popular among youth.
Key points
- The proposal extends registration and product-listing obligations to foreign manufacturers as well as domestic producers who make, prepare or process tobacco products.
- Major global tobacco firms named as potentially affected include British American Tobacco, Japan Tobacco and Imperial Brands; smaller overseas e-cigarette manufacturers could also be impacted.
- Manufacturers would be required to submit detailed product information electronically and to update facility registrations yearly and product listings twice annually.
Risks and uncertainties
- The rule is currently a proposal - it would need to be finalized before the requirements become enforceable, creating uncertainty about timing and final scope.
- Potential compliance burden for foreign manufacturers and smaller overseas e-cigarette producers is implied by the requirement to provide detailed product and technical data and to maintain periodic updates.
- The proposal's success in addressing illegal imports, including youth-popular e-cigarettes, depends on the rule's implementation and the agency's ability to inspect foreign facilities effectively.